Literature DB >> 8564213

Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon.

P M Kerr1, K Hillier, R M Wallis, C J Garland.   

Abstract

1. The effects of seven muscarinic receptor antagonists were used to characterize the receptors which mediate carbachol-evoked contractions of intertaenial circular and taenial longitudinal muscle in human isolated colon. The effects of these antagonists were studied upon colon contractions induced by cumulatively added carbachol which had mean EC50 values of 11.7 +/- 2.3 microM (n = 8) and 12.6 +/- 2.3 microM (n = 8) respectively upon circular and longitudinal smooth muscle. 2. All antagonists displaced concentration-response curves to carbachol to the right in a parallel manner. The maximum concentration of each antagonist added (30 nM-10 microM) did not significantly suppress the maximum response. 3. In circular muscle, the M3 muscarinic receptor antagonists, 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP), hexahydrosiladiphenidol (HHSiD) and para-fluoro-hexahydrosiladiphenidol (p-F-HHSiD) inhibited responses with pA2 values of 9.41 +/- 0.23, 7.17 +/- 0.07, 6.94 +/- 0.18 respectively. The M2 muscarinic receptor antagonist, AF-DX 116, the M2/M4 muscarinic receptor antagonist, himbacine, and the M1 muscarinic receptor antagonist, pirenzepine, yielded pA2 values of 7.36 +/- 0.43, 7.47 +/- 0.14 and 7.23 +/- 0.48 respectively. The non-selective antagonist, atropine, had a pA2 of 8.72 +/- 0.28. 4. In longitudinal muscle 4-DAMP, HHSiD, p-F-HHSiD, AF-DX 116, himbacine and pirenzepine gave pA2 values of 9.09 +/- 0.16, 7.45 +/- 0.43, 7.44 +/- 0.21, 6.44 +/- 0.1, 7.54 +/- 0.40, 6.87 +/- 0.38 respectively. Atropine yielded a pA2 value of 8.60 +/- 0.08. 5. The pharmacological profile of antagonist affinities at the muscarinic receptor population responding to muscarinic agonist-evoked contraction is similar to that widely accepted as characterizing the activation of an M3 muscarinic receptor subtype, although pA2 values of some antagonists are lower than that seen in other investigations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564213      PMCID: PMC1908871          DOI: 10.1111/j.1476-5381.1995.tb16645.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Interaction of p-F-HHSiD (p-Fluoro-hexahydrosila-difenidol) at muscarinic receptors in guinea-pig trachea.

Authors:  R M Eglen; C M Cornett; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

2.  Muscarinic receptor subtypes in human and rat colon smooth muscle.

Authors:  A Gómez; F Martos; I Bellido; E Marquez; A J Garcia; J Pavia; F Sanchez de la Cuesta
Journal:  Biochem Pharmacol       Date:  1992-06-09       Impact factor: 5.858

3.  Pharmacology of the putative M4 muscarinic receptor mediating Ca-current inhibition in neuroblastoma x glioma hybrid (NG 108-15) cells.

Authors:  M P Caulfield; D A Brown
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.

Authors:  J H Miller; P J Aagaard; V A Gibson; M McKinney
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

5.  Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors.

Authors:  C Russo; M Marchi; G C Andrioli; P Cavazzani; M Raiteri
Journal:  J Pharmacol Exp Ther       Date:  1993-07       Impact factor: 4.030

6.  Pharmacological profiles of muscarinic receptors in the longitudinal smooth muscle of guinea pig ileum.

Authors:  K Honda; Y Takano; H Kamiya
Journal:  Jpn J Pharmacol       Date:  1993-05

7.  Affinity profiles of pizotifen, ketotifen and other tricyclic antimuscarinics at muscarinic receptor subtypes M1, M2 and M3.

Authors:  M Eltze; E Mutschler; G Lambrecht
Journal:  Eur J Pharmacol       Date:  1992-02-18       Impact factor: 4.432

8.  Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.

Authors:  M T Griffin; F J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  1992-10       Impact factor: 4.030

9.  Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.

Authors:  C Bolden; B Cusack; E Richelson
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  11 in total

Review 1.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

2.  Antiinflammatory effect of phytosterols in experimental murine colitis model: prevention, induction, remission study.

Authors:  Rita Aldini; Matteo Micucci; Monica Cevenini; Romana Fato; Christian Bergamini; Cristina Nanni; Massimiliano Cont; Cecilia Camborata; Silvia Spinozzi; Marco Montagnani; Giulia Roda; Antonia D'Errico-Grigioni; Francesca Rosini; Aldo Roda; Giuseppe Mazzella; Alberto Chiarini; Roberta Budriesi
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

3.  Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders.

Authors:  Muhammad Nabeel Ghayur; Anwarul Hassan Gilani
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

4.  Functional interactions between muscarinic M2 receptors and 5-hydroxytryptamine (5-HT)4 receptors and beta 3-adrenoceptors in isolated oesophageal muscularis mucosae of the rat.

Authors:  R M Eglen; B Peelle; M T Pulido-Rios; E Leung
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

5.  Cholinergic activation of enteric glia is a physiological mechanism that contributes to the regulation of gastrointestinal motility.

Authors:  Ninotchska M Delvalle; David E Fried; Gretchen Rivera-Lopez; Luke Gaudette; Brian D Gulbransen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

6.  Modulation of chloride, potassium and bicarbonate transport by muscarinic receptors in a human adenocarcinoma cell line.

Authors:  N D Holliday; H M Cox
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

7.  Cholinergic facilitation of neurotransmission to the smooth muscle of the guinea-pig prostate gland.

Authors:  W A Lau; J N Pennefather; F J Mitchelson
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

8.  Differential responsiveness to contractile agents of isolated smooth muscle cells from human colons as a function of age and inflammation.

Authors:  J C Boyer; C Guitton; C Pignodel; P Cuq; P Moussu; P Pouderoux; M O Christen; J L Balmes; J P Bali
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

9.  Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.

Authors:  Helena-F Wrzos; Tarun Tandon; Ann Ouyang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

10.  A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trials.

Authors:  Jan Tack; Jean-Jacques Wyndaele; Greg Ligozio; Mathias Egermark
Journal:  Drug Healthc Patient Saf       Date:  2012-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.